Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?
Eli Lilly's spate of acquisitions is building out multiple areas of its pipeline at once.
Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?
Overview
Eli Lilly (NYSE: LLY) spent a lot of 2026 on a shopping spree. Riding an obesity drug windfall, the company has announced more than $25 billion in acquisitions across roughly 10 deals this year, with seven of them reported in the last three months alone.
The purchases cover areas such as sleep medicine, blood cancers, cell therapy, and vaccines. In other words, Lilly is diversifying beyond metabolic medicine. But which of the new acquisitions will be the most important for the future of the company?
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.
